The case involves 55-year-old Augusta Turiaco from Messina, Sicily, who received her COVID jab on March 11, but started experiencing severe symptoms a few days later.
The legal proceedings launched by the family are just one of a number of cases across Europe being mounted against AstraZeneca.

Source:Zero Hedge
While American lawmakers have taken steps to shield US pharma companies from any legal blowback caused by COVID vaccines, drugmakers in Europe haven’t been so lucky. And after widespread skepticism of the AstraZeneca-Oxford vaccine, what was supposed to be the workhorse of the global immunization rollout before reports of rare and deadly blood clots inspired regulators around the comment to either halt the jab, or impose limits on its use.
And now, all these issues will be dredged up again as AstraZeneca is hit by lawsuits filed by the families of those who died from rare blood clots potentially linkted to the vaccine. In what appears to be a first, Sky News reported Monday that the family of an Italian woman who died from a case…
View original post 431 more words
Very sad story. I pray that the family wins their lawsuit. This clotting disorder is not so “rare” now. The clot seem to form in the same place in all the brains of most of the suffering patients. It is called Cerebral Venous Sinus Thrombosis. A clot forms in a vein which drains blood from the brain. The brain needs constant replenishing with oxygen in order to function and this clot interferes with that. A stroke or death will occur if not treated right away. Stat!
LikeLiked by 1 person
In my experience, Mary Anne, for the government to allow mass vaccination of the population with a product that has never been thoroughly safety tested on animals or people. It’s unbelievable!
LikeLiked by 1 person
All the governments of the world too … in some seeort of synch!. It’s madness!
LikeLike
Too right, Mary Anne. Western governments have lost all credibility. Except for their most ardent supporters, I don’t think people are ever going to take them seriously again.
LikeLiked by 1 person